If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
540.00    -11.00 (-2.00%)
Bid:
542.00
Ask:
545.00
Spread: 3.00 (0.554%)
Market Cap: £995.07m
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Update on Move to the Main Market

7 Apr 2026 07:00

RNS Number : 3553Z
Volex PLC
07 April 2026
 

 

LEI: 213800HBLQNH5FXXGE63

7 April 2026

Volex plc

("Volex", the "Company", or the "Group")

Update on Move to the Main Market

 

Volex plc (AIM: VLX), the specialist integrated manufacturer of critical power and data transmission products, today provides an update on its proposed move to the Main Market.

 

Confirmation of intention to move from AIM to the Main Market

 

Further to the announcement of 25 March 2026, and following consultation with the Company's largest shareholders, the Board of Volex today confirms its intention to apply to the Financial Conduct Authority (the "FCA") for admission of all of the Company's ordinary shares of 25 pence each (the "Ordinary Shares") to the equity shares (commercial companies) category of the Official List of the FCA, and to trading on the Main Market of London Stock Exchange plc (the "London Stock Exchange") ("Admission").

 

Admission is subject to the approval by the FCA of a prospectus, its admission of the Ordinary Shares to listing on the Official List, and admission by the London Stock Exchange of the Ordinary Shares to trading on the Main Market. Admission is not conditional upon shareholder approval. The Company is targeting Admission prior to 4 August 2026 (being the date by which Admission must be effective in order to meet the 20 day minimum trading requirement to be eligible for inclusion in the FTSE Russell's September 2026 Quarterly Review of the FTSE 250 Index). On and subject to Admission occurring, the Company's listing on AIM will be cancelled. Shareholders should note that the Company's shares will no longer be traded on AIM with effect from Admission and should consult their own professional advisers regarding the consequences of Admission.

 

The Company will provide a further update on the timeline and process through to Admission in due course.

 

Launch of share buyback programme

 

Volex has also announced today that the Board has approved and launched a share buyback programme to return up to £40 million to shareholders, further details of which are set out in a separate announcement.

 

Capital Markets Event

 

As previously announced, Volex will host a Capital Markets Event for institutional investors and analysts at 14.00 on Wednesday 22 April 2026 at the offices of Peel Hunt LLP, 100 Liverpool Street, London. The event will set out the Company's new medium-term growth targets.

 

Institutional investors who are interested in attending in person should contact Sodali at Volex@sodali.com.

 

 

-ENDS-

 

For further information please contact:

 

Volex plc

+44 (0) 1256 442570

Nat Rothschild, Chief Executive Officer

investor.relations@volex.com

Jon Boaden, Chief Financial Officer

Peel Hunt LLP - Nominated Adviser & Joint Broker

+44 (0) 20 7418 8900

Ed Allsopp

Dom Convey

Charlotte Sutcliffe

Tom Graham

Jefferies - Joint Broker

+44 (0) 20 7029 8000

Philip Noblet

Sam Barnett

Harry Le May

Sodali & Co. - Media Enquiries

+44 (0) 20 7250 1446

James White

Nicholas Johnson

 

About Volex plc

Volex plc (AIM:VLX) is a driving force in integrated manufacturing for mission-critical applications and a global leader in power and data connectivity solutions. Our diverse operations support international blue-chip customers in five key end-markets: Electric Vehicles, Consumer Electricals, Medical, Complex Industrial Technology and Off-Highway. Headquartered in the UK, we orchestrate operations across 23 advanced manufacturing facilities, uniting 13,000 dynamic individuals from 25 different nations. Our extraordinary products find their way to market through our localised sales teams and authorised distributor partners, supporting Original Equipment Manufacturers and Electronic Manufacturing Services companies across the globe. In a world that grows more digitally complex by the day, customers trust us to deliver power and connectivity that drives everything from household essentials to life-saving medical equipment. Learn more at www.volex.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSSAFMMEMSEDL
Date   Source Headline
25th Jun 20267:00 amRNSPreliminary Group Results FY2026
25th Jun 20267:00 amRNSUpdate on Move to the Main Market
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.